Static Chart Vertex Pharmaceuticals Incorporated

Stocks

Market Closed - Nasdaq 00:00:00 03/09/2026 +04			5-day change	1st Jan Change
556.75 ^USD	+1.66%		+1.73%	+22.81%

09-02	Evercore ISI Adjusts Vertex Pharmaceuticals Price Target to $600 From $535, Maintains Outperform Rating	MT
09-02	Vertex Pharmaceuticals Incorporated Announces Chief Financial Officer Changes, Effective January 1, 2027	CI

Duration

Period